SCHEMBL2991930

SCHEMBL2991930

CC(C)(C)C(c1ccc(C=O)cc1)c1ccc(OCc2ccccn2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.73
SMN1; SMN2 Q16637 3/20 0.73
KDM4E B2RXH2 2/20 0.73
HPGD P15428 2/20 0.53
PARP10 Q53GL7 1/20 0.46
LMNA P02545 2/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
MAOB P27338 1/20 0.42
ALOX5 P09917 1/20 0.41
ADAMTS4 O75173 1/20 0.41
RAB9A P51151 1/20 0.41
ALOX5AP P20292 1/20 0.40
TLR4 O00206 1/20 0.40
TLR2 O60603 1/20 0.40
PDE10A Q9Y233 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13268124 0.89 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2KDM4EHPGDPARP10
SCHEMBL13267971 0.86 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2KDM4EHPGDPARP10
SCHEMBL509499 0.85 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2KDM4EHPGDPARP10
SCHEMBL13248546 0.84 PARP10 (0.49) ALDH1A1SMN1; SMN2KDM4EHPGDPARP10
SCHEMBL3001931 0.83 TLR4 (0.60) ALDH1A1SMN1; SMN2KDM4EHPGDPARP10
SCHEMBL3001935 0.83 TLR4 (0.60) ALDH1A1SMN1; SMN2KDM4EHPGDPARP10
SCHEMBL2992851 0.82 PARP10 (0.57) ALDH1A1SMN1; SMN2KDM4EPARP10MAOB
SCHEMBL2251349 0.82 PARP10 (0.57) ALDH1A1SMN1; SMN2KDM4EHPGDPARP10
SCHEMBL13268171 0.81 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2KDM4EHPGDLMNA
SCHEMBL3005551 0.81 MAOB (0.47) ALDH1A1SMN1; SMN2KDM4EHPGDPARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2546232-A1 Diphenyl Substituted Alkanes Merck Sharp & Dohme Corp. (US) 2013-01-16 EP disclosed
US-20100190761-A1 DIPHENYL SUBSTITUTED ALKANES MERCK SHARP & DOHME CORP. 2010-07-29 US disclosed
US-20100190761-A1 DIPHENYL SUBSTITUTED ALKANES MERCK SHARP & DOHME CORP. 2010-07-29 US disclosed
US-20100190761-A1 DIPHENYL SUBSTITUTED ALKANES MERCK SHARP & DOHME CORP. 2010-07-29 US disclosed
WO-2008156721-A1 DIPHENYL SUBSTITUTED ALKANES MERCK & CO., INC. (US) 2008-12-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190761-A1 DIPHENYL SUBSTITUTED ALKANES ALOX5, ALOX15, ALOX15B ALDH1A1 159/4885SMN1; SMN2 4219/4885KDM4E 2671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.